Chemoinformaics analysis of 1,3-Dioxolane-2-propanoic acid, 2-methyl-, ethyl ester
| Molecular Weight | 188.223 | nRot | 4 |
| Heavy Atom Molecular Weight | 172.095 | nRig | 6 |
| Exact Molecular Weight | 188.105 | nRing | 1 |
| Solubility: LogS | -0.696 | nHRing | 1 |
| Solubility: LogP | 0.851 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 28.9067 |
| nHD | 0 | BPOL | 22.1273 |
| QED | 0.619 |
| Synth | 2.577 |
| Natural Product Likeliness | 0.093 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.004 |
| Pgp-sub | 0 |
| HIA | 0.001 |
| CACO-2 | -4.353 |
| MDCK | 0.0000499 |
| BBB | 0.866 |
| PPB | 0.263454 |
| VDSS | 1.061 |
| FU | 0.601668 |
| CYP1A2-inh | 0.063 |
| CYP1A2-sub | 0.51 |
| CYP2c19-inh | 0.391 |
| CYP2c19-sub | 0.76 |
| CYP2c9-inh | 0.036 |
| CYP2c9-sub | 0.122 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.214 |
| CYP3a4-inh | 0.018 |
| CYP3a4-sub | 0.292 |
| CL | 11.645 |
| T12 | 0.838 |
| hERG | 0.083 |
| Ames | 0.168 |
| ROA | 0.007 |
| SkinSen | 0.371 |
| Carcinogencity | 0.084 |
| EI | 0.904 |
| Respiratory | 0.017 |
| NR-Aromatase | 0.028 |
| Antiviral | No |
| Prediction | 0.929507 |